The Music, Sleep and Dementia Study
Primary Purpose
Dementia, Alzheimer Disease, Circadian Rhythm Disorders
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Tailored music listening intervention
Sponsored by
About this trial
This is an interventional supportive care trial for Dementia
Eligibility Criteria
Inclusion Criteria:
- Age 60 and older
- Physician diagnosis of probable ADRD using standard assessments and diagnostic criteria
- Presence of sleep problems determined first during phone screening using NPI sleep disorders item, then using proxy-rated Sleep Disorders Inventory (SDI) (presence of at least one sleep disturbance symptom of moderate severity)
- Stable dose of psychotropic medications, sedatives/hypnotics, anti-dementia or opioids in the past 90 days (typical time frame in clinical trials) prior to enrollment to minimize confounding effects of medications
- Tolerates and agrees to wear wrist actigraph
- Responsive to their environment (e.g., able to understand short commands)
- Sufficient English to complete questionnaires
Exclusion Criteria:
- Planned transition to another residential or institutional care setting in less than 3 months
- Hearing impairment (defined as inability to hear a normal speaking voice at a distance of 1-1/2 feet)
- Presence of extrapyramidal symptoms affecting non-dominant hand which may include persons with the following diagnoses: schizophrenia, bipolar disorder, Huntington's disease, Parkinson's disease, Lewy Body dementia due to REM sleep disorders
- Currently enrolled in an interventional clinical trial for ADRD aimed to improve sleep
- Acute sleep disruption within 2 weeks of screening as it may indicate sleep disorders not related to ADRD or delirium
- End stage disease (i.e. cancer, bed bound)
Sites / Locations
- University of Pennsylvania
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Experimental: Tailored Music
4-week Wait-list control
Arm Description
4-week tailored music listening intervention delivered to persons with dementia and their caregivers via a tablet.
4-week wait-list control (Note: participants will be crossed over to 4-week tailored music listening intervention delivered to persons with dementia and their caregivers via a tablet)
Outcomes
Primary Outcome Measures
Study Measures Completion
Number of participants who complete study measures in accordance with protocol schedule of events
Study Measures Completion
Number of participants who complete study measures in accordance with protocol schedule of events
Acceptability of the study components
Two questions from a survey developed by Gitlin and colleagues (2010) which examines satisfaction with participation and perceived benefits.
The survey uses a scale of 1-3 (1- Not at all to 3-A great deal) to rate caregiver perceived 1) overall benefit from participating in the study and 2) improvement in life of person's with dementia.
Min score 2, maximum score 6 (with higher scores indicating greater satisfaction and perceived benefits)
Secondary Outcome Measures
Objective sleep measures
Measured using an actigraphy bracelet worn by person with dementia for consecutive 24-hour periods for 4 weeks. The actigraph will measure: 1) Sleep latency (Time it takes a person to fall asleep starting from first intention to sleep); 2) Wake after sleep onset (Time awake during the night, beginning from the time person falls asleep); 3) Total sleep duration (Actual time person is asleep)
The Quality of Life in Alzheimer's Disease Scale (QOL-AD)
Person with dementia quality of life. The QOL-AD scale uses a scale of 1-4 (poor, fair, good, or excellent) to rate a variety of life domains, including the patient's physical health, mood, relationships, activities, and ability to complete tasks.
Full Information
NCT ID
NCT04157244
First Posted
October 7, 2019
Last Updated
January 12, 2021
Sponsor
University of Pennsylvania
1. Study Identification
Unique Protocol Identification Number
NCT04157244
Brief Title
The Music, Sleep and Dementia Study
Official Title
The Feasibility of a Tailored Music Intervention to Reduce Symptoms of Sleep Disruption in Older Adults With Dementia
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
March 12, 2019 (Actual)
Primary Completion Date
January 12, 2021 (Actual)
Study Completion Date
January 12, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The specific aims of this studyare to examine the 1) feasibility; 2) acceptability; and 3) preliminary efficacy of a tailored music intervention in home-dwelling older adults with dementia suffering from sleep disruption. Sixty dyads (older adults with dementia and their caregivers) will be randomized to receive the tailored music intervention immediately or following a four week delay.
Detailed Description
Sleep disruption in older adults living with Alzheimer's disease and related dementias (ADRD) is very debilitating and contributes to increased institutionalization, reduced cognitive function, and accelerated disease progression. Furthermore, sleep disruption is linked to poor health outcomes in caregivers (CGs), such as poor quality of life and increased CG burden. Given the potential harmful side effects of pharmacologic treatment, non-pharmacologic approaches, such as music, may provide a safer alternative to reducing sleep disruption in this vulnerable population. Listening to music has been shown to decrease agitation, anxiety and depression in nursing home residents with ADRD. A growing body of literature suggests that individualized music may improve sleep quality in older adults with early memory loss, but its efficacy has not been demonstrated in older adults with ADRD in the community, where most older adults with ADRD live. If proven feasible and acceptable, tailored music interventions can then be tested for efficacy in reducing sleep disruption.
Music selections will be individualized to older adults with ADRD and account for known sleep-inducing properties. Feasibility of processes that are key to the success of the subsequent study will be examined. Preliminary efficacy of the intervention will be assessed using objective (actigraphy) and subjective (proxy reported) sleep quality measures. In addition, qualitative data will be solicited from the dyads examining the acceptability and satisfaction with the intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia, Alzheimer Disease, Circadian Rhythm Disorders, Circadian Rhythm Sleep Disorder, Insomnia, Hypersomnia, Cognitive Impairment, Cognitive Decline, Mild Cognitive Impairment, Frontotemporal Dementia, Neurocognitive Disorders, Vascular Dementia, Sleep Disorder, Memory Impairment
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Wait-list controlled design
Masking
None (Open Label)
Allocation
Randomized
Enrollment
32 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Experimental: Tailored Music
Arm Type
Experimental
Arm Description
4-week tailored music listening intervention delivered to persons with dementia and their caregivers via a tablet.
Arm Title
4-week Wait-list control
Arm Type
No Intervention
Arm Description
4-week wait-list control (Note: participants will be crossed over to 4-week tailored music listening intervention delivered to persons with dementia and their caregivers via a tablet)
Intervention Type
Behavioral
Intervention Name(s)
Tailored music listening intervention
Intervention Description
The music intervention consists of listening to preferred soothing music at bedtime for 30 minutes every night for four weeks (28 sessions total). This theory based caregiver-assisted intervention builds on the evidence-based protocol of using individualized music to decrease agitation in nursing home residents. It also accounts for sleep-inducing properties of music.
Primary Outcome Measure Information:
Title
Study Measures Completion
Description
Number of participants who complete study measures in accordance with protocol schedule of events
Time Frame
Baseline
Title
Study Measures Completion
Description
Number of participants who complete study measures in accordance with protocol schedule of events
Time Frame
4 weeks
Title
Acceptability of the study components
Description
Two questions from a survey developed by Gitlin and colleagues (2010) which examines satisfaction with participation and perceived benefits.
The survey uses a scale of 1-3 (1- Not at all to 3-A great deal) to rate caregiver perceived 1) overall benefit from participating in the study and 2) improvement in life of person's with dementia.
Min score 2, maximum score 6 (with higher scores indicating greater satisfaction and perceived benefits)
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Objective sleep measures
Description
Measured using an actigraphy bracelet worn by person with dementia for consecutive 24-hour periods for 4 weeks. The actigraph will measure: 1) Sleep latency (Time it takes a person to fall asleep starting from first intention to sleep); 2) Wake after sleep onset (Time awake during the night, beginning from the time person falls asleep); 3) Total sleep duration (Actual time person is asleep)
Time Frame
4 weeks
Title
The Quality of Life in Alzheimer's Disease Scale (QOL-AD)
Description
Person with dementia quality of life. The QOL-AD scale uses a scale of 1-4 (poor, fair, good, or excellent) to rate a variety of life domains, including the patient's physical health, mood, relationships, activities, and ability to complete tasks.
Time Frame
Baseline and 4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
110 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age 60 and older
Physician diagnosis of probable ADRD using standard assessments and diagnostic criteria
Presence of sleep problems determined first during phone screening using NPI sleep disorders item, then using proxy-rated Sleep Disorders Inventory (SDI) (presence of at least one sleep disturbance symptom of moderate severity)
Stable dose of psychotropic medications, sedatives/hypnotics, anti-dementia or opioids in the past 90 days (typical time frame in clinical trials) prior to enrollment to minimize confounding effects of medications
Tolerates and agrees to wear wrist actigraph
Responsive to their environment (e.g., able to understand short commands)
Sufficient English to complete questionnaires
Exclusion Criteria:
Planned transition to another residential or institutional care setting in less than 3 months
Hearing impairment (defined as inability to hear a normal speaking voice at a distance of 1-1/2 feet)
Presence of extrapyramidal symptoms affecting non-dominant hand which may include persons with the following diagnoses: schizophrenia, bipolar disorder, Huntington's disease, Parkinson's disease, Lewy Body dementia due to REM sleep disorders
Currently enrolled in an interventional clinical trial for ADRD aimed to improve sleep
Acute sleep disruption within 2 weeks of screening as it may indicate sleep disorders not related to ADRD or delirium
End stage disease (i.e. cancer, bed bound)
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
20662955
Citation
Gitlin LN, Winter L, Dennis MP, Hodgson N, Hauck WW. Targeting and managing behavioral symptoms in individuals with dementia: a randomized trial of a nonpharmacological intervention. J Am Geriatr Soc. 2010 Aug;58(8):1465-74. doi: 10.1111/j.1532-5415.2010.02971.x. Epub 2010 Jul 19.
Results Reference
background
PubMed Identifier
20810376
Citation
Gitlin LN, Winter L, Dennis MP, Hodgson N, Hauck WW. A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial. JAMA. 2010 Sep 1;304(9):983-91. doi: 10.1001/jama.2010.1253.
Results Reference
background
PubMed Identifier
36000763
Citation
Jespersen KV, Pando-Naude V, Koenig J, Jennum P, Vuust P. Listening to music for insomnia in adults. Cochrane Database Syst Rev. 2022 Aug 24;8(8):CD010459. doi: 10.1002/14651858.CD010459.pub3.
Results Reference
derived
Learn more about this trial
The Music, Sleep and Dementia Study
We'll reach out to this number within 24 hrs